Zobrazeno 1 - 10
of 14
pro vyhledávání: '"R. G. Gataulin"'
Autor:
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, K. K. Osadchiy, R. G. Gataulin, K. A. Oganesyan, N. V. Lobova, Z. B. Jafarova
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 4, Pp 516-521 (2020)
Aim. To study changes in vascular wall stiffness in patients with obesity and paroxysmal atrial fibrillation (AF) during sinus rhythm retention.Material and methods. The study included 86 obese patients aged 38 to 72 years. Patients were divided into
Externí odkaz:
https://doaj.org/article/4268b36ae24b453d8d4fb35676143c33
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 18, Iss 4, Pp 109-114 (2019)
Atrial fibrillation (AF) is one of the most common heart rhythm disorders. AF worsens the quality of life of patients and increases the risk of fatal cardiovascular complications. Obesity is a worldwide epidemic which prevalence has doubled in the pa
Externí odkaz:
https://doaj.org/article/c1fd424dfde2435da78524119941017e
Role of epicardial adipose tissue in the development of atrial fibrillation in hypertensive patients
Autor:
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, K. K. Osadchiy, R. G. Gataulin, K. A. Oganesyan, Z. B. Jafarova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 6 (2020)
Obesity is a progressing epidemic, the prevalence of which has doubled over the past 30 years. The distribution of adipose tissue is an important factor in predicting the risk of cardiovascular events. The most significant inflammatory activity is ch
Externí odkaz:
https://doaj.org/article/47592b2510424097940a59615773771c
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 3, Pp 319-323 (2018)
Aim. To study the changes in the stiffness of the arterial wall, vasomotor function of the endothelium, and appearance of new cases of atrial fibrillation (AF) in patients with arterial hypertension with long-term treatment with lisinopril.Material a
Externí odkaz:
https://doaj.org/article/2e67f1d5b9054658b7d0bcbfc42bc608
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 5, Pp 517-521 (2016)
Aim. To study the effect of atorvastatin on the progression of the arrhythmia in hypertensive patients with paroxysmal atrial fibrillation (AF) in the longterm follow-up.Material and methods. Patients with paroxysmal AF (n=65) were included into the
Externí odkaz:
https://doaj.org/article/6562007ce164436c911ac14e79ae5a59
Autor:
N. V. Lobova, R. G. Gataulin, K. K. Osadchiy, A. I. Tarzimanova, Karine Oganesyan, Z. B. Jafarova, Valery Podzolkov, A. E. Bragina
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 4, Pp 516-521 (2020)
Aim. To study changes in vascular wall stiffness in patients with obesity and paroxysmal atrial fibrillation (AF) during sinus rhythm retention.Material and methods. The study included 86 obese patients aged 38 to 72 years. Patients were divided into
Publikováno v:
European Heart Journal. 41
Aim To study the influence of epicardial fat tissue (EFT) on atrial fibrillation (AF) occurrence in hypertensive patients. Materials and methods The study included 195 patients with hypertension aged from 38 to 72 years (mean age was 61.5±1.8 years)
Autor:
A. I. Tarzimanova, A. E. Bragina, M V Pisarev, Valery Podzolkov, K A Oganesian, R. G. Gataulin
Publikováno v:
EP Europace. 22
Objective To study the changes in arterial stiffness in patients with obesity and paroxysmal atrial fibrillation (AF). Materials and methods The study included 82 obese patients. Forty-two of them (group I) had paroxysmal AF, their mean age was 60.9
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 14, Iss 3, Pp 319-323 (2018)
Aim. To study the changes in the stiffness of the arterial wall, vasomotor function of the endothelium, and appearance of new cases of atrial fibrillation (AF) in patients with arterial hypertension with long-term treatment with lisinopril.Material a
Publikováno v:
European Heart Journal. 40
Objective To identify predictors of progression of atrial fibrillation (AF) in patients with hypertension, coronary heart disease (CHD) and chronic heart failure (CHF) with recurrent AF. Materials and methods The study included 312 patients with recu